Lundbeck: Regions prioritize clinical research
According to drug group Lundbeck, it has become more generally accepted in Denmark that healthcare professionals spend time and resources on clinical research.
BY STEFAN SINGH KAILAY
In the research department in the Danish drug company Lundbeck they are eyeing a change in the public sector's attitude towards clinical research and collaboration with Denmark’s pharmaceutical industry.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Here is why Roche opted for Danish partnership
For abonnenter
Novartis strikes deal with Danish region
For abonnenter
